Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (51-60 of 324) with videos related to

Pageof 33
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 25, 2020
The Challenges of Parameterizing Direct Effects in Individual-Level Simulation ModelsEleanor J Murray, James M Robins, George R Seage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Acute human immunodeficiency virus infection in patients presenting to an urban urgent care centerJonathan M Pincus, Sondra S Crosby, Elena Losina, et al.
Journal of Viral Hepatitis|September 9, 2025
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B CureAmir M Mohareb, Ghideon Ezaz, Arthur Y Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Effectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overviewElena Losina, Runa Islam, Alison C Pollock, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 9, 2002
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDSBruce R Schackman, Sue J Goldie, Kenneth A Freedberg, et al.
Vaccine|August 19, 2003
Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccinationThomas Hanslik, Pierre-Yves Boëlle, Michael Schwarzinger, et al.
HIV Clinical Trials|April 14, 2009
Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documentsAndrea L Ciaranello, Rochelle P Walensky, Paul E Sax, et al.
AIDS (London, England)|November 5, 2008
Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicityAndrea L Ciaranello, George R Seage, Kenneth A Freedberg, et al.
AIDS (London, England)|September 12, 2008
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIVBruce R Schackman, Callie A Scott, Rochelle P Walensky, et al.
The Pediatric Infectious Disease Journal|January 11, 2013
Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapyCatherine Orrell, Julie Levison, Andrea Ciaranello, et al.
Pageof 33

Showing results (51-60 of 324) with videos related to

Sort By:
Pageof 33
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 25, 2020
The Challenges of Parameterizing Direct Effects in Individual-Level Simulation ModelsEleanor J Murray, James M Robins, George R Seage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Acute human immunodeficiency virus infection in patients presenting to an urban urgent care centerJonathan M Pincus, Sondra S Crosby, Elena Losina, et al.
Journal of Viral Hepatitis|September 9, 2025
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B CureAmir M Mohareb, Ghideon Ezaz, Arthur Y Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Effectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overviewElena Losina, Runa Islam, Alison C Pollock, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 9, 2002
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDSBruce R Schackman, Sue J Goldie, Kenneth A Freedberg, et al.
Vaccine|August 19, 2003
Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccinationThomas Hanslik, Pierre-Yves Boëlle, Michael Schwarzinger, et al.
HIV Clinical Trials|April 14, 2009
Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documentsAndrea L Ciaranello, Rochelle P Walensky, Paul E Sax, et al.
AIDS (London, England)|November 5, 2008
Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicityAndrea L Ciaranello, George R Seage, Kenneth A Freedberg, et al.
AIDS (London, England)|September 12, 2008
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIVBruce R Schackman, Callie A Scott, Rochelle P Walensky, et al.
The Pediatric Infectious Disease Journal|January 11, 2013
Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapyCatherine Orrell, Julie Levison, Andrea Ciaranello, et al.
Pageof 33